Impact of a protein-based assay that predicts prostate cancer aggressiveness on urologists’ recommendations for active treatment or active surveillance: a randomized clinical utility trial

Peer Review reports

Original Submission
13 Jul 2016	Submitted	Original manuscript
20 Mar 2017	Reviewed	Reviewer Report - Christopher Filson
7 Apr 2017	Reviewed	Reviewer Report - Jeffrey Tosoian
12 May 2017	Author responded	Author comments - John Peabody
Resubmission - Version 2
12 May 2017	Submitted	Manuscript version 2
16 May 2017	Reviewed	Reviewer Report - Christopher Filson
29 May 2017	Reviewed	Reviewer Report - Jeffrey Tosoian
Resubmission - Version 3
	Submitted	Manuscript version 3
Publishing
27 Jun 2017	Editorially accepted
3 Jul 2017	Article published	10.1186/s12894-017-0243-1

Back to article page